Abstract:Local anesthetics are mainly used for regional anesthesia and analgesia. However, the duration of action is limited in clinical applications. In the present study, we developed a ropivacaine (RPC)-loaded mesoporous bioactive glass (MBG) microspheres for an extended analgesic duration. First, MBG microspheres were prepared using a template synthesis method. RPC was then loaded into the MBG microspheres through immersion, followed by centrifugation and drying. Finally, the RPC-loaded MBG microspheres were coated with a polylactic acid-b-polyethylene glycol (PLA-PEG) copolymer to obtain RPC-MBG composite microspheres (RPC microspheres). The particle size and zeta potential of the RPC microspheres were 192.3 ± 9.6 nm and −35.6 ± 3.5 mV, with entrapment efficiency (EE) of 88.2 ± 3.2% and low cytotoxicity. In vitro, the release profile of RPC microspheres exhibited a biphasic pattern: an initial release burst within the first hour, followed by subsequent slower and sustained release. After performing a single-shot sciatic nerve block, a fast the anesthetic effect and prolonged analgesic effect were achieved. Given the low cytotoxicity and sustained release, the RPC microspheres developed in this study could be used as a long-acting local anesthetic.<ol class="links-for-figure"><li><a class="anchor download-link u-font-sans" href="https://ars.els-cdn.com/content/image/1-s2.0-S1773224720303890-fx1_lrg.jpg">Download : Download high-res image (163KB)</a></li><li><a class="anchor download-link u-font-sans" href="https://ars.els-cdn.com/content/image/1-s2.0-S1773224720303890-fx1.jpg">Download : Download full-size image</a></li></ol>

What problem does this paper attempt to address?

The main problem that this paper attempts to solve is to improve the continuous analgesic effect of the local anesthetic Ropivacaine (RPC) in clinical applications. Specifically, the researchers developed a Ropivacaine - loaded Mesoporous Bioactive Glass Microspheres (MBG) to achieve a longer - lasting analgesic effect. This method aims to overcome the limitation that traditional Ropivacaine can only provide a short - term analgesic effect (6 - 12 hours) after injection, so as to meet the needs of long - term postoperative pain management. ### Research Background and Objectives - **Clinical Needs**: Acute postoperative pain is usually the most severe within the first three days after surgery, but in some thoracic and orthopedic surgeries (such as joint replacement), the pain may last for a week, requiring long - term functional rehabilitation. Although existing local anesthetic drugs can temporarily and reversibly block nerve conduction to achieve a satisfactory analgesic effect, their duration of action is limited and cannot fully meet clinical needs. - **Insufficiencies of Existing Solutions**: In order to prolong the analgesic time, various methods have been clinically attempted, including intermittent injection, continuous drug administration through catheters, increasing the drug concentration or dose, and adding adjuvant drugs such as adrenaline, dexamethasone or dexmedetomidine. However, these methods carry risks such as high cost, catheter displacement, infection, and drug accumulation. - **Research Objectives**: To develop a new type of Ropivacaine - loaded mesoporous bioactive glass microspheres to achieve a rapid - onset and long - lasting analgesic effect while maintaining low cytotoxicity. ### Research Methods - **Material Preparation**: Mesoporous bioactive glass microspheres were prepared by the template synthesis method, and Ropivacaine was loaded into the microspheres by the immersion method. Subsequently, the surface of the microspheres was coated with a polylactic acid - polyethylene glycol (PLA - PEG) copolymer, and finally, the Ropivacaine - loaded composite microspheres (RPC microspheres) were obtained. - **Performance Evaluation**: The morphology, particle size, polydispersity index (PDI) and ζ - potential of RPC microspheres were evaluated by means of transmission electron microscopy (TEM), dynamic light scattering (DLS) and ζ - potential measurement. In addition, the drug loading and encapsulation efficiency were also determined. - **In vitro Release Experiment**: The drug release behavior of RPC microspheres was studied by dialysis technology. - **Cytotoxicity and Pharmacodynamic Evaluation**: In vitro cytotoxicity tests were carried out using BALB/c - 3T3 fibroblasts, and the in vivo pharmacodynamic characteristics of RPC microspheres were evaluated by heat - radiation pain test and 4 - point functional scoring method. ### Main Findings - **Physicochemical Properties**: The particle size of RPC microspheres is about 192.3 ± 9.6 nm, the PDI is 0.12 ± 0.01, the ζ - potential is −35.6 ± 3.5 mV, and the encapsulation efficiency is 88.2 ± 3.2%. - **Drug Release**: RPC microspheres exhibit a biphasic release pattern, with about 20% rapidly released within the first hour, followed by a slow and continuous release, and more than 90% released after 7 days. - **Cytotoxicity**: RPC microspheres have a relatively small and insignificant impact on cell viability in the range of 1 - 100 μM. - **Pharmacodynamics**: RPC microspheres reach the maximum analgesic effect within 0.5 hours after injection and maintain it for at least 120 hours. In contrast, the analgesic effect of the free RPC solution only lasts for about 4 hours. ### Conclusions By loading Ropivacaine into mesoporous bioactive glass microspheres and coating their surfaces, the researchers have successfully developed RPC microspheres with small particle size, narrow PDI, high encapsulation efficiency, low cytotoxicity and in vitro continuous release characteristics. In vivo experiments show that a single sciatic nerve block injection of RPC microspheres can produce a good anesthetic effect and continue to play an analgesic role in the following five days. Therefore, this RPC microsphere is expected to be used as a safe and long - acting local anesthetic in clinical practice.

Preparation of ropivacaine-loaded mesoporous bioactive glass microspheres and evaluation of their efficacy for sciatic nerve block

Precision-guided long-acting analgesia by Gel-immobilized bupivacaine-loaded microsphere.

Construction of bupivacaine‐loaded gelatin‐based hydrogel delivery system for sciatic nerve block in mice

Mesoporous Silica Particles As a Multifunctional Delivery System for Pain Relief in Experimental Neuropathy.

Effect Analysis of Epidural Anesthesia with 0.4% Ropivacaine in Transforaminal Endoscopic Surgery.

Long-term sciatic nerve block lead by supramolecular arrangement of self-delivery local anesthetic nano systems

Mussel-inspired Injectable Microbubbles Delivery System for Drug Ultrasound Contrast and Long-lasting Analgesic Effect in Peripheral Nerve Block

Injectable Hydrogel Delivery System with High Drug Loading for Prolonging Local Anesthesia.

Preparation, characterization and in vivo efficacy evaluation of ropivacaine O/W emulsion by premix membrane emulsification

Porous Core/Dense Shell PLA Microspheres Embedded with High Drug Loading of Bupivacaine Crystals for Injectable Prolonged Release

Achieving Long-Acting Local Analgesia Using an Intelligent Hydrogel Encapsulated with Drug and Ph Regulator.

Injectable electrospun fiber-hydrogel composite sequentially releasing clonidine and ropivacaine for prolonged and walking regional analgesia

Effects Of Liposomes Charge On Extending Sciatic Nerve Blockade Of N-Ethyl Bromide Of Lidocaine In Rats

Near-infrared triggered ropivacaine liposomal gel for adjustable and prolonged local anaesthesia

Epidural Sustained Release Ropivacaine Prolongs Anti-Allodynia and Anti-Hyperalgesia in Developing and Established Neuropathic Pain

Ropivacaine-loaded, hydroxypropyl chitin thermo-sensitive hydrogel combined with hyaluronan: an injectable, sustained-release system for providing long-lasting local anesthesia in rats

Recent research and development of local anesthetic-loaded microspheres

Prolonged Anesthesia Effects of Locally Administered Ropivacaine via Electrospun Poly(caprolactone) Fibrous Membranes

Injectable PLGA-coated Ropivacaine Produces a Long-Lasting Analgesic Effect on Incisional Pain and Neuropathic Pain.

An in Situ-Forming Phospholipid-Based Phase Transition Gel Prolongs the Duration of Local Anesthesia for Ropivacaine with Minimal Toxicity.

Injectable thermosensitive lipo-hydrogels loaded with ropivacaine for prolonging local anesthesia